e-learning
resources
European Respiratory Review
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Systematic review of drug effects in humans and models with surfactant-processing disease
Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel
Source:
Eur Respir Rev, 27 (149) 170135; 10.1183/16000617.0135-2017
Journal Issue:
September
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel. Systematic review of drug effects in humans and models with surfactant-processing disease. Eur Respir Rev, 27 (149) 170135; 10.1183/16000617.0135-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD)
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Prediction models for the development of COPD: a systematic review
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Current evidence for COVID-19 therapies: a systematic literature review
Source: Eur Respir Rev, 30 (159) 200384; 10.1183/16000617.0384-2020
Year: 2021
Systematic review and MAIC of OCS reduction with biologic asthma treatments
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Clinical effectiveness and models of pulmonary rehabilitation in low-resource-settings: a systematic review
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
As needed therapies in mild to severe asthma: a systematic review and network meta-analysis
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Genetic polymorphisms of the adrenergic ß2-receptor in COPD: systematic review and meta-analyses of disease risk and treatment response
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Rate and impact of the infection risk related to reusable flexible bronchoscopes: Systematic literature review and meta-analysis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
The use of pharmacological therapies in hospitalized COVID-19 patients– A literature review
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
A systematic review of prognostic models in COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Year: 2021
Pesticide exposure and lung function: a systematic review and meta-analysis
Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Year: 2019
Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Investigating asthma comorbidities: a systematic scoping review
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018
The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
Source: Eur Respir Rev, 29 (155) 190057; 10.1183/16000617.0057-2019
Year: 2020
The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis
Source: Eur Respir J, 58 (6) 2100266; 10.1183/13993003.00266-2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept